Further Refinement is Required for Patient-Reported Outcome Scales for Respiratory Diseases Based on Traditional Chinese Medicine Theory for Applicability

被引:0
作者
Zhang, Peng [1 ,2 ]
Ren, Jiaming [1 ]
Xu, Baichuan [1 ]
Wang, Jiajia [2 ,3 ,4 ,5 ]
Xie, Yang [2 ,3 ,4 ,5 ]
机构
[1] Henan Univ Chinese Med, Clin Med Coll 1, Zhengzhou, Henan, Peoples R China
[2] Henan Univ Chinese Med, Affiliated Hosp 1, Dept Resp Dis, Zhengzhou, Henan, Peoples R China
[3] Henan Univ Chinese Med, Collaborat Innovat Ctr Chinese Med & Resp Dis Coc, Zhengzhou, Peoples R China
[4] Henan Univ Chinese Med, Educ Minist PR China, Zhengzhou, Peoples R China
[5] Henan Univ Chinese Med, Henan Key Lab Chinese Med Resp Dis, Zhengzhou, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2023年 / 16卷
关键词
patient-reported outcome; quality of life; respiratory disease; traditional Chinese medicine; COSMIN; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; SYSTEMATIC REVIEWS; COSMIN; ASSESSMENTS; VALIDATION;
D O I
10.2147/IJGM.S438297
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To summarize the contents and assess the methodological quality and measurement properties of the patient-reported outcome (PRO) scales featured with Traditional Chinese Medicine (TCM) for respiratory diseases based on the guideline of COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN). Biology Medicine (CBM) were searched for studies on PRO scales featured with TCM for respiratory diseases from their inception until December 2022. The characteristics of the PRO scales were qualitatively summarized. Following the COSMIN guideline, the risk of bias was assessed according to the checklist, and different measurement properties (content validity, structural validity, internal consistency, reliability, criterion validity, and responsiveness) were evaluated. Finally, the evidence's overall quality was assessed, and the recommendation was formulated using the modified GRADE approach. Results: A total of 13 scales were included, with 6 for chronic obstructive pulmonary disease (COPD), 3 for lung cancer, 2 for idiopathic pulmonary fibrosis (IPF), 1 for community-acquired pneumonia (CAP), and 1 for bronchiectasis. All 13 scales are diseasespecific scales and were developed based on Chinese cultural background to measure the efficacy of TCM. The study did not provide information on measurement error, cross-cultural validity, and hypothesis testing for the construct validity of these measures. No scale was rated as sufficient in content validity and responsiveness. Two scales showed sufficient structural validity, while 11 scales exhibited sufficient internal consistency. Three scales demonstrated sufficient reliability, and 7 scales showed sufficient criterion validity. All 13 scales have a recommendation level of B. Conclusion: The 13 scales could reflect the clinical efficacy of TCM and are suitable for the Chinese population. Nevertheless, the validation of these scales was not comprehensive enough, and the methodological quality of their studies needs to be further strengthened.
引用
收藏
页码:6099 / 6113
页数:15
相关论文
共 47 条
[1]   Maximising the impact of patient reported outcome assessment for patients and society [J].
Calvert, Melanie ;
Kyte, Derek ;
Price, Gary ;
Valderas, Jose M. ;
Hjollund, Niels Henrik .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 364
[2]   Comparative effectiveness of phlegm-heat clearing Chinese medicine injections for AECOPD: A systematic review and network meta-analysis [J].
Chen, Xueyin ;
Kang, Fuqin ;
Lai, Jiaqi ;
Deng, Xueyi ;
Guo, Xinfeng ;
Liu, Shaonan .
JOURNAL OF ETHNOPHARMACOLOGY, 2022, 292
[3]   Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis [J].
Cox, Ingrid A. ;
Arriagada, Nicolas Borchers ;
de Graaff, Barbara ;
Corte, Tamera J. ;
Glaspole, Ian ;
Lartey, Stella ;
Walters, E. Haydn ;
Palmer, Andrew J. .
EUROPEAN RESPIRATORY REVIEW, 2020, 29 (158) :1-22
[4]   Confirmatory factor analysis of the general activities of daily living scale: further evidences of internal validity [J].
de Paula, Jonas Jardim ;
Albuquerque, Maicon Rodrigues ;
Camargos Bicalho, Maria Aparecida ;
Romano-Silva, Marco Aurelio .
REVISTA BRASILEIRA DE PSIQUIATRIA, 2017, 39 (04) :379-380
[5]  
DeVellis R.F., 2016, SCALE DEV THEORY APP
[6]  
Diao J, 2007, Study on Quality of Life Scale in Patient with Advance Lung Cancer
[7]   Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments [J].
Elsman, Ellen B. M. ;
Butcher, Nancy J. ;
Mokkink, Lidwine B. ;
Terwee, Caroline B. ;
Tricco, Andrea ;
Gagnier, Joel J. ;
Aiyegbusi, Olalekan Lee ;
Barnett, Carolina ;
Smith, Maureen ;
Moher, David ;
Offringa, Martin .
SYSTEMATIC REVIEWS, 2022, 11 (01)
[8]  
FDA, 2022, CDER patient-focused drug development
[9]   Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance [J].
不详 .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[10]   COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures [J].
Gagnier, Joel J. ;
Lai, Jianyu ;
Mokkink, Lidwine B. ;
Terwee, Caroline B. .
QUALITY OF LIFE RESEARCH, 2021, 30 (08) :2197-2218